<DOC>
	<DOCNO>NCT00011063</DOCNO>
	<brief_summary>This study examine herbal remedy ginkgo biloba may affect body 's elimination medicine . Many people take ginkgo biloba improve memory , mental alertness overall feeling well . Since product consider food supplement drug , subject rigorous pre-market testing require prescription over-the-counter ( OTC ) drug . As result , information collect possible interaction ginkgo biloba medication . This study look ginkgo biloba affect elimination phenytoin-a medication use treat patient seizures . Normal healthy volunteer 21 year age old may eligible 40-day study . Candidates provide medical history undergo physical examination routine blood test . Women childbearing age must use reliable form birth control oral contraceptive ( `` pill '' ) . For least 2 week study throughout duration , study participant may follow : 1 ) medication affect platelet function ( e.g. , aspirin , Motrin , Advil , Nuprin , ibuprofen , etc . ) ; 2 ) alcoholic beverage ; 3 ) grapefruit grapefruit juice ; 4 ) medication except give study personnel . On day 1 study , subject take one 500-mg dose phenytoin 8:00 A.M.. On empty stomach . ( Subjects fast night take phenytoin allow eat breakfast 2 hour dose ) . Blood sample draw dose 0.5 , 1 , 1.5 , 2 , 4 , 6 , 8 , 10 , 12 , 24 , 32 , 48 , 72 96 hour dose . Blood drawn first study day collect catheter ( small plastic tube ) place vein avoid multiple needlesticks . After 12-hour sample collect , subject go home return clinic remain blood draw , take direct needlestick . When blood sampling complete , subject begin ginkgo therapy . The NIH Clinical Center provide participant supply 60-mg capsule ginkgo take twice day ( 8 A.M. 8 P.M.. ) 4 week . At end 4 week , subject give second dose phenytoin describe repeat blood sample procedure . Subjects continue take ginkgo second phenytoin study .</brief_summary>
	<brief_title>Effect Ginkgo Biloba Phenytoin Elimination</brief_title>
	<detailed_description>Gingko biloba complementary alternative medication use purport cognitive enhancing effect . Despite widespread use limit data regard potential drug interaction . The purpose study determine effect administration ginkgo 4 week single dose phenytoin pharmacokinetics . Eight healthy volunteer take single 500mg dose phenytoin capsule orally serial blood sample collect 96 hour determination phenytoin pharmacokinetics . Following pharmacokinetic study subject begin take 2 , 60mg capsule ( 120mg total ) ginkgo twice daily 28 day . Following 28 day ginkgo subject undergo phenytoin pharmacokinetic evaluation blood sample obtain 96 hour determination phenytoin pharmacokinetics . The ratio geometric mean phenytoin pharmacokinetic parameter value 90 % confidence interval ratio log transform parameter value calculate . Confidence interval fall within 80-125 % range characterize pharmacokinetic parameter value ginkgo equivalent .</detailed_description>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Male female . Healthy medical history physical exam . Age great 21 year old . No concurrent medication . Nonsmoker ( least 6 month prior history smoking ) . Laboratory value wihin follow guideline : AST/SGOT le equal 1.5 time upper limit normal ; bilirubin less equal upper limit normal ; serum creatinine less equal upper limit normal ; hemoglobin great equal 10 g/dl ; albumin NML . Females childbearing potential must use reliable form birth control hormonal contraceptive . No concomitant therapy inhibitor inducer cytochrome P450 mediate drug metabolism within 30 day study . Must ability remain free chronic medication alcohol least 2 week prior study . No use oral contraceptive ( phenytoin , potentially ginko , may induce clearance oral contraceptive lead potential oral contraceptive failure ) . Must ability willingness avoid analgesic antiplatelet activity least 2 week prior study . No presence renal , hepatic , cardiovascular , hematologic , neurologic , psychiatric , respiratory disease condition may interfere interpretation study result best interest subject opinion principal investigator . No positive serum pregnancy test . No presence persistent diarrhea malabsorption would interfere patient 's ability adequately absorb drug . No drug alcohol use may impair safety adherence .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>Anti-Epileptic</keyword>
	<keyword>CYP2C9</keyword>
	<keyword>Herbal</keyword>
	<keyword>Interaction</keyword>
	<keyword>Metabolism</keyword>
	<keyword>Drug Interaction</keyword>
	<keyword>Drug Metabolism</keyword>
	<keyword>Ginko Biloba</keyword>
	<keyword>Healthy Volunteer</keyword>
</DOC>